PreEvnt recently announced plans to introduce Isaac, its non-invasive alert device for monitoring blood glucose levels.

Left, the Dexcom G7 CGM. Right, the Abbott FreeStyle Libre 2. [Images from Dexcom and Abbott] Abbott (NYSE:ABT) announced today that it reached an agreement with Dexcom (Nasdaq:DXCM) to settle all ...

The FDA has issued a warning letter related to BD Pyxis automated medication dispensing systems — technology that was part of its $12 billion CareFusion acquisition in 2015. The warning letter, dated ...

The Mobi miniature, durable automated insulin patch pump worn on a hiker’s leg. [Image courtesy of Tandem Diabetes Care] There has been no shortage of news across the diabetes and drug delivery ...

A pickleball player wears the Stelo over-the-counter CGM. [Image courtesy of Dexcom] Dexcom (Nasdaq:DXCM) announced today that it launched a proprietary generative AI platform integrated with its ...

Left, the Dexcom G7 CGM. Right, the Abbott FreeStyle Libre 2. [Images from Dexcom and Abbott] The Unified Patent Court in Paris sided with Abbott (NYSE:ABT) following a CGM patent infringement claim ...

Qnovia’s nicotine replacement therapy device. [Image courtesy of Qnovia] Qnovia announced that it raised $16 million in Series B funding to support its inhaled smoking cessation therapy platform. Blue ...

Embecta (Nasdaq:EMBC) filed with the state of Massachusetts to confirm a workforce reduction affecting 118 employees. The state received Embecta’s Worker Adjustment and Retraining Notification (WARN) ...

The Vivani NanoPortal technology. [Image courtesy of Vivani] Vivani Medical (Nasdaq:VANI) announced today that it initiated screening and enrollment for a first-in-human trial of its GLP-1 implant.

The Cardinal Health Monoject insulin syringes. [Image from the FDA] The FDA deemed a recall of Cardinal Health (NYSE:CAH) insulin syringe luer lock packs as type I, the most serious kind of recall.